Clinical Trial Update: Imaging of Prostate Cancer Using Two-dimensional MR Spectroscopy and Diffusion Tensor Imaging [NA]

View source ↗

Summary

A clinical trial evaluating imaging of prostate cancer using two-dimensional MR spectroscopy and diffusion tensor imaging has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University of California, Irvine | Conditions: Prostate Lesions | NA | Status: WITHDRAWN